Related Experiment Video
Updated: Jun 12, 2026

Procedure for Human Saphenous Veins Ex Vivo Perfusion and External Reinforcement
Published on: October 1, 2014
Embolic protection during saphenous vein graft interventions
Subhash Banerjee1, Emmanouil S Brilakis
1VA North Texas Healthcare System, 4500 S. Lancaster Road (111a), Dallas, TX, 75216, USA. subhash.banerjee@utsouthwestern.edu
Insights
Saphenous vein graft stenting risks heart attack from emboli. Embolic protection devices prevent this, but are underused. This review updates data and offers guidance on using these devices during interventions.
Area of Science:
- Interventional Cardiology
- Vascular Surgery
- Cardiovascular Research
Background:
- Saphenous vein graft (SVG) stenting carries a high risk of periprocedural myocardial infarction.
- Distal embolization is the primary cause of myocardial infarction during SVG interventions.
- Embolic protection devices (EPDs) are clinically proven to prevent myocardial infarction during SVG interventions.
Purpose of the Study:
- To provide an update on clinical data for embolic protection devices in SVG interventions.
- To offer practical recommendations for the use of available EPDs.
- To encourage wider adoption of EPDs in eligible patients.
Main Methods:
- Review of current clinical trial data on embolic protection devices.
- Analysis of practical considerations for device deployment.
- Synthesis of expert recommendations for SVG intervention protocols.
Main Results:
- EPDs are the only therapy with clinical trial evidence for preventing periprocedural myocardial infarction during SVG stenting.
- Despite proven efficacy, EPDs are underutilized in current clinical practice.
- Available EPDs offer varying degrees of embolic protection and ease of use.
Conclusions:
- Embolic protection devices are crucial for mitigating the risk of myocardial infarction during SVG stenting.
- Increased awareness and practical guidance can improve the utilization of EPDs.
- Optimizing EPD use can enhance patient outcomes following SVG interventions.
Abstract:
Stenting of saphenous vein graft (SVG) lesions is associated with a high risk of periprocedural myocardial infarction, due primarily to distal embolization. Although embolic protection devices are the only clinical trial-proven therapy for preventing periprocedural myocardial infarction during SVG interventions, they are currently used in only a small proportion of eligible patients. In this review, we present an update on the clinical data and practical recommendations for using the currently available embolic protection devices during SVG interventions.
More Related Videos
09:04Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Aneurysm IV: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management